2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Ross, Douglas S., Burch, Henry B., Cooper, David S., Greenlee, M. Carol, Laurberg, Peter, Maia, Ana Luiza, Rivkees, Scott A., Samuels, Mary +3 more·2016·Thyroid®

Cited by (1,000)

Items 701–800 of 1,000

  1. Treatment of Graves’ disease in children: The Portuguese experience
    Olinda Marques, Ana Antunes, Maria João Oliveira · 2018 · Endocrinología Diabetes y Nutrición
  2. Subclinical hypothyroidism: new trials, old caveats
    Faïza Lamine, Sara De Giorgi, Laura Marino, Marina A. Michalaki, Gerasimos P. Sykiotis · 2018 · HORMONES
  3. Syndrome of thyrotoxicosis. Differential diagnosis and treatment
    Galina Afanas'evna Mel'nichenko, I. M. Larina · 2018 · Terapevticheskii arkhiv
  4. Vascularity-Targeted Percutaneous Ethanol Injection of Toxic Thyroid Adenomas: Outcomes of A Feasibility Study Performed in the USA
    Anu Rani Sharma, Dev Abraham · 2019 · Endocrine Practice
  5. Endocrine disorders after heart transplantation: national cohort study
    Matej Rakuša, Bojan Vrtovec, Gregor Poglajen, Andrej Janež, Mojca Jensterle · 2020 · BMC Endocrine Disorders
  6. Eosinophil/Monocyte Ratio Combined With Serum Thyroid Hormone for Distinguishing Graves' Disease and Subacute Thyroiditis
    Yongbin Hu, Diyi Zhou, Jiawei Chen, Peng‐Fei Shan · 2020 · Frontiers in Endocrinology
  7. Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus 2019 guidelines. Short version
    Bernard Goichot, Véronique Raverot, Marc Klein, Lavinia Vija Racaru, Juliette Abeillon-du Payrat, Olivier Lairez, Rémy Leroy, Anne Cailleux, Pierre Wolff, Lionel Groussin et al. · 2020 · Annales d Endocrinologie
  8. Thyroid effects of amiodarone: clinical update
    Poorani Nallam Goundan, Stephanie L. Lee · 2020 · Current Opinion in Endocrinology Diabetes and Obesity
  9. Prevalence and Risk Factors of Left Ventricular Diastolic Dysfunction in Patients With Hyperthyroidism
    Huan Li, Renli Zeng, Yunfei Liao, Mengfei Fu, Huan Zhang, Linfang Wang, Yuming Li · 2021 · Frontiers in Endocrinology
  10. Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review
    Jun Li, Litao Bai, Fan Wei, Maoying Wei, Yao Xiao, Weitian Yan, Junping Wei · 2021 · Frontiers in Endocrinology
  11. Predisposition to Graves’ disease and Graves’ ophthalmopathy by genetic variants of IL2RA
    Juan Du, Xin Wang, Guiqin Tan · 2021 · Journal of Molecular Medicine
  12. Recurrence of Graves’ Disease: What Genetics of HLA and PTPN22 Can Tell Us
    Daniela Vejražková, Josef Včelák, Eliška Václavíková · 2021 · Frontiers in Endocrinology
  13. Diagnostic Tests: Investigating thyroid nodules
    Nisha Venkatesh, Jui T. Ho · 2021 · Australian Prescriber
  14. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis
    Nathalie Silva de Morais, Trevor E. Angell, Sara Ahmadi, Erik Karl Alexander, Patrícia de Fátima dos Santos Teixeira, Ellen Marqusee · 2022 · Endocrine Practice
  15. TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease
    Sébastien Verdickt, Falco van Nes, Carolien Moyson, Toon Maes, Paul Van Crombrugge, Annick Van den Bruel, Brigitte Decallonne · 2022 · European Thyroid Journal
  16. Approach to the Patient: Management and the Long-term Consequences of Graves' Disease in Children
    Scott A. Rivkees · 2022 · The Journal of Clinical Endocrinology & Metabolism
  17. Xiehuo Xiaoying decoction inhibits Tfh cell expansion and promotes Tfr cell amplification to ameliorate Graves’ disease
    Pingping Xiang, Yunnan Zhang, Xiaoyang Qu, Yu Chen, Yijiao Xu, Xingjia Li, Xiao Wei, Xin Hu, Ronglin Zhong, Chao Liu et al. · 2022 · Journal of Ethnopharmacology
  18. A Literature Review on SARS-CoV-2 and Other Viruses in Thyroid Disorders: Environmental Triggers or No-Guilty Bystanders?
    Francesca Gorini, Cristina Vassalle · 2023 · International Journal of Environmental Research and Public Health
  19. Effects of Inorganic Iodine Therapy Administered to Lactating Mothers With Graves Disease on Infant Thyroid Function
    Katsuhiko Hamada, Tetsuya Mizokami, Tetsushi Maruta, K Higashi, Kaoru Konishi, Naoko Momotani, Junichi Tajiri · 2017 · Journal of the Endocrine Society
  20. Overexpression of pulmonary surfactant protein A like molecules in inflammatory bowel disease tissues.
    Junming Luo, Zhaoqian Liu, Chin Y Eugene · 2008 · PubMed
  21. Long‐term outcomes of anti‐thyroid drug treatment in childhood‐onset Graves' disease
    Dolrutai Puttawong, Pat Mahachoklertwattana, Pawin Numthavaj, Patarawan Woratanarat, Sarunyu Pongratanakul, Peeravit Koad, Preamrudee Poomthavorn · 2022 · Clinical Endocrinology
  22. Outcomes of Surgical Treatment for Graves’ Disease: A Single-Center Experience of 216 Cases
    Hanxing Sun, Hui Tong, Xiaohui Shen · 2023 · Journal of Clinical Medicine
  23. Incidence, Risk Factors, and Outcomes of Incident Atrial Fibrillation in Patients With Graves Disease
    Jwan A. Naser, Sorin V. Pislaru, Marius Nicolae Stan, Grace Lin · 2023 · Mayo Clinic Proceedings
  24. Approach to management of hypo and hyperthyroidism in Bangladesh: a nationwide physicians’ perspective survey
    Shahjada Selim, Marufa Mustari, Tawshique Ahmed Khan, Abul B. M. Kamrul-Hasan · 2024 · Frontiers in Endocrinology
  25. Plasmapheresis in thyrotoxicosis: a single-center case series
    Imane Rami, Dounia Zerrouki, Imane Assarrar · 2024 · Journal of Medical Case Reports
  26. Paraneoplastic Hyperthyroidism in Advanced Testicular Non-Seminomatous Germ Cell Tumors: Prevalence and Clinical Management
    Markus Angerer, Bendix Hansen, Christian Wülfing · 2024 · Oncology
  27. Clinical factors influencing the success rate of radioiodine treatment for Graves' disease
    Meiwen He, Limeng Pan, Yifan Li, Yue Wang, Xing Zhong, Yijun Du, Tianrong Pan · 2024 · Diabetes Obesity and Metabolism
  28. Extraocular muscle Diffusion Weighted Imaging as a quantitative metric of posterior orbital involvement in thyroid associated orbitopathy
    Nicole George, Claire Feeney, Vickie Lee · 2024 · Insights into Imaging
  29. Preoperative Preparation in Hyperthyroidism and Surgery in the Hyperthyroid State
    Mehmet Uludağ · 2024 · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
  30. Iodine and Hyperthyroidism: A Double-Edged Sword
    Kate D. Braverman, Elizabeth N. Pearce · 2024 · Endocrine Practice
  31. Management of perioperative thyrotoxicosis – what to do when standard therapy is contraindicated or fails?
    Kristy Tian, Trilene Liang, Jielin Yew · 2024 · Frontiers in Endocrinology
  32. Exploring Current Diagnosis and Management of Amiodarone-induced Thyrotoxicosis
    Yudi Her Oktaviano, Ali Mustofa, Pandit Bagus Tri Saputra, Wynne Widiarti, Novia Nurul Faizah, Firas Farisi Alkaff · 2025 · The American Journal of Cardiology
  33. Chimeric autoantibody receptor T cells specifically eliminate Graves’ Disease autoreactive B cells
    Abigail Cheever, Hunter G. Lindsay, Chloe Kang · 2025 · Frontiers in Immunology
  34. Evaluation of the Current State of Thyroid Hormone Testing in Human Serum—Results of the Free Thyroxine and Thyrotropin Interlaboratory Comparison Study
    Ashley Ribera, Otoe Sugahara, Tatiana Buchannan, Norma Vazquez, Alicia N. Lyle, Li Zhang, Uliana Danilenko, Hubert W. Vesper · 2025 · Thyroid
  35. Thyroid Ultrasonography: Much Ado About Nothing? A Provocative Analysis
    Petra Petranović Ovčariček, Luca Giovanella · 2025 · Cancers
  36. Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
    Rudolf Hoermann, John E. M. Midgley, Rolf Larisch, Johannes W. Dietrich · 2020 · Journal of Clinical & Translational Endocrinology
  37. Hyperthyroidism Is Associated with the Development of Vasospastic Angina, but Not with Cardiovascular Outcomes
    Hyun‐Jin Kim, Sang‐Ho Jo, Min‐Ho Lee, Won‐Woo Seo, Sang Hong Baek · 2020 · Journal of Clinical Medicine
  38. Speckle tracking echocardiographic assessment of left ventricular longitudinal strain in female patients with subclinical hyperthyroidism
    Randa R. Abdelrazk, Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mohamed G. M. Ghoniem, Maged Z. Amer · 2020 · Cardiovascular Endocrinology & Metabolism
  39. Computer-Aided Diagnosis of Thyroid Dysfunction: A Survey
    Bhavisha S. Parmar, Mayuri A. Mehta · 2020 · Lecture notes in computer science
  40. Current approach to surgical management of hyperthyroidism
    Marcin Barczyński · 2021 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
  41. Use of YouTube as an Information Source for Radioactive Iodine Therapy: Do YouTube Videos Have High Quality?
    Hüseyin Şan · 2022 · Molecular Imaging and Radionuclide Therapy
  42. Audit of long‐term treatment outcomes of thyrotoxicosis in a single‐centre virtual clinic: The utility of long‐term antithyroid drugs
    Miles J Levy, Narendra L. Reddy, David E. Price, Ragini C Bhake, Emma Bremner, Mary Barrowcliffe, Veronica Kieffer, Carole Robinson, Francesco Zaccardi, Trevor A. Howlett · 2022 · Clinical Endocrinology
  43. Use of Lithium in Hyperthyroidism Secondary to Graves’ Disease: A Case Report
    Pranjali P. Sharma · 2022 · American Journal of Case Reports
  44. Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism
    Joachim N. Nilsson, Rebecca Elovsson, Daniel Thor, Jan Calissendorff, Oscar Ardenfors · 2022 · Thyroid Research
  45. Anti-thyroid antibodies and underlying generalized immunologic aberrations in patients with reproductive failures
    Samaneh Abdolmohammadi‐Vahid, Vajihe Samaie, Huriyeh Hashemi, Amir Mehdizadeh, Sanam Dolati, Fatemeh Ghodrati-khakestar, Mitra Niafar, Mehdi Yousefi · 2022 · Journal of Reproductive Immunology
  46. Operative Management of Thyroid Disease in Older Adults
    Jina Kim, Carolyn Dacey Seib · 2023 · Journal of the Endocrine Society
  47. Subacute Thyroiditis Complicating COVID-19 Infection
    Katrin Henke, Jonas Odermatt, Mairi Ziaka, Natalia N. Rudovich · 2023 · Clinical Medicine Insights Case Reports
  48. Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database
    Ji Yun Han, Jun Myong Lee, Se Yong Jung et al. · 2024 · Fundamental and Clinical Pharmacology
  49. Interpretable machine learning model predicting immune checkpoint inhibitor‐induced hypothyroidism: A retrospective cohort study
    Suyan Zhu, Tongtong Yang, Yi‐Zhuo Zhao, Yu Sun, Xiaomeng Zheng, Hongbin Xu · 2024 · Cancer Science
  50. 131I-Induced Graves’ disease in patients treated for toxic multinodular goitre: systematic review and descriptive analysis
    Catarina Roque, C. A. Vasconcelos · 2018 · Journal of Endocrinological Investigation
  51. Rapid Changes of Thyroid Function in a Young Woman with Autoimmune Thyroid Disease
    Christian Trummer, Verena Theiler‐Schwetz, Felix Aberer · 2019 · Medical Principles and Practice
  52. Methimazole-Induced Leukocytoclastic Vasculitis: A Case Report
    Weeratian Tawanwongsri, Pamela Chayavichitsilp · 2019 · Case Reports in Dermatology
  53. Prevalence of thyroid dysfunction and thyroid autoimmunity in polycystic ovary syndrome: A multicenter study from Bangladesh
    Abul B. M. Kamrul-Hasan, Fatema Tuz Zahura Aalpona, Marufa Mustari, Farhana Akter, Palash Kumar Chanda, Mohammad Motiur Rahman, MohammadImtiaj Mahbub, Shahjada Selim · 2020 · Thyroid Research and Practice
  54. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation
    Pınar Ataca Atilla, Erman Akkuş, Erden Atilla, Neslihan Gökmen İnan, Sinem Civriz Bozdağ, Meltem Kurt Yüksel, Selami Kocak Toprak, Nilgün Başkal, Hamdi Akan, Taner Demirer et al. · 2020 · Clinical Transplantation
  55. Plasmapheresis in the treatment of multi-drug intoxication involving levothyroxine sodium and calcium channel blockers: a case report
    Ran Li, Yong-Wei Xu, Ying Xue, Xianzheng Wu · 2020 · Annals of Palliative Medicine
  56. Effectiveness of radioactive iodine (131I) in the treatment of Graves' disease: single center experience in Assiut University hospital.
    Nsreen R. A. Mohamadien, Mohamed Hm Sayed · 2020 · PubMed
  57. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
    Sriram Gubbi, Mohammad Al-Jundi, Jaydira Del Rivero et al. · 2021 · Frontiers in Endocrinology
  58. Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report
    Hiroyuki Yamamoto, Satoshi Monno, Keiko Ohta‐Ogo, Hatsue Ishibashi‐Ueda, Toru Hashimoto · 2021 · BMC Cardiovascular Disorders
  59. A Chinese survey on clinical practice in hyperthyroidism management: comparison with recent studies and guidelines
    Xichang Wang, Xiaochun Teng, Chenyan Li, Yushu Li, Jing Li, Weiping Teng, Zhongyan Shan, Yaxin Lai · 2021 · Endocrine Connections
  60. Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
    Jinhui Zeng, Fangtao Luo, Zhihua Lin, Yinghong Chen, Xiaoyun Wang, Yuanhao Song · 2021 · BMC Endocrine Disorders
  61. Comprehensive Metabolomics Study in Children With Graves’ Disease
    Xia Qin, Weifeng Qian, Linqi Chen, Xiuli Chen, Rongrong Xie, Dandan Zhang, Haiying Wu, Hui Sun, Fengyun Wang, Jingjing Liu et al. · 2021 · Frontiers in Endocrinology
  62. Pericardial Manifestations of Thyroid Diseases
    Johnny Chahine, Zeina Jedeon, Kevin Y. Chang, Christine Louise Jellis · 2022 · Current Cardiology Reports
  63. Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation
    Martina Chiera, Stefano Draghetti, Diana De Ronchi, Anna Rosa Scaramelli, Chiara Fabbri, Giuseppe Fanelli, Alessandro Serretti · 2023 · International Clinical Psychopharmacology
  64. Safety and efficacy of prophylactic treatment for hyperthyroidism induced by iodinated contrast media in a high-risk population
    Jacopo Manso, Ilaria R. Piva, Simona Censi, Cristina Clausi, Maria Bardi, Benedetta Schiavon, Isabella Merante Boschin, Francesco Tona, Caterina Mian · 2023 · Frontiers in Endocrinology
  65. Comparison of two different TSH-receptor antibody assays: A clinical practice study
    Mathé van Balkum, Marco W.J. Schreurs, W. Edward Visser, Robin Patrick Peeters, Willem A. Dik · 2023 · Heliyon
  66. Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach
    Valentina Topić Vučenović, Zvezdana Rajkovača, Dijana Jelić, Dragi Stanimirović, Goran Vuleta, Branislava Miljković, Katarina M. Vučićević · 2018 · European Journal of Clinical Pharmacology
  67. A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs ( ATD ) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
    Hyunsam Kim, Jeongmin Lee, Jeonghoon Ha · 2018 · Clinical Case Reports
  68. Sexual function and depressive symptoms in men with overt hyperthyroidism
    Robert G. Krysiak, Bogdan Marek, Bogusław Okopień · 2019 · Endokrynologia Polska
  69. Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease
    Natalia Wijaya, Celeste Ong-Ramos · 2019 · Journal of the ASEAN Federation of Endocrine Societies
  70. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves’ disease
    Patrícia Novais Rabelo, Paula Novais Rabelo, Allyne Fernanda de Paula, Samuel Amanso da Conceição, Daniela Pultrini Pereira de Oliveira Viggiano, Daniela Espíndola Antunes, Estela Muszkat Jatene, Sílvia Leda França Moura de Paula, Monike Lourenço Dias Rodrigues, Maria Aparecida Lopes Reis · 2019 · Revista da Associação Médica Brasileira
  71. Thyrotoxic hypokalemic periodic paralysis triggered by dexamethasone administration
    Polamaung, Waraporn, Kongkit, Jaruwan, Yimnoi, Parichat, Boonchaya-Anant, Patchaya, Snabboon, Thiti · 2020 · Acta Medica (Hradec Kralove, Czech Republic)
  72. Evaluation of the application of TSH receptor stimulating autoantibodies and the optimization of detection strategy in Graves’ disease
    Minghong Tong, Jun Ding, Biao Huang, Jindan Chen, Xin Wei, Zhiming Li, Jie Shu, Zhigang Hu, Xiaohong Jiang, Huiming Sheng · 2021 · Clinica Chimica Acta
  73. The Complex Web of Interferences with Thyroid Function Tests
    Al-Bahadili, Huda, Powers Carson, Jennifer, Markov, Alexander, Jasim, Sina · 2025 · Endocrine Practice
  74. Effect of preoperative potassium iodide administration on Graves’ disease surgery: a propensity score analysis
    Alberto G. Barranquero, José Luis Muñoz de Nova, Joaquín Gómez-Ramírez, Álvaro Valdés de Anca, Belén Porrero, Lara Blanco Terés, S. Garrote Corral, Elena Martín‐Pérez · 2021 · The American Journal of Surgery
  75. Tireotoxicose Induzida pela Amiodarona - Revisão de Literatura e Atualização Clínica
    Luciana Vergara Ferraz de Souza, Maria Thereza Campagnolo, Luiz Claudio Behrmann Martins, Maurício Scanavacca · 2021 · Arquivos Brasileiros de Cardiologia
  76. Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessions
    Elif Tutku Durmuş, Ayşegül Akın Atmaca, Düzgün Özatlı, Ramis Çolak, Buğra Durmuş · 2022 · Endocrine
  77. National Trends and Outcomes in the Operative Management of Thyroid Storm
    Young‐Ji Seo, Nikhil L. Chervu, Peyman Benharash · 2024 · The American Surgeon
  78. Clinical manifestations and risk factors of immune-related thyroid adverse events in patients treated with PD-1 inhibitors: a case-control study
    Pengfei Zhao, Jia Li, Lihong Yu, Wenming Ma, Ting Zhao · 2025 · Frontiers in Immunology
  79. The evolving therapeutic landscape of Graves’ disease in adults: present and future
    Marius Nicolae Stan, Chrysoula Dosiou · 2025 · European Thyroid Journal
  80. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors
    Ling Zhu, Yee-Ming Melody Cheung, Cherie Ying Chiang, Emily J. Gallagher, Ole‐Petter R. Hamnvik, Jennifer Sophie Mammen, Zoe Quandt, Renisha Jones, Jon McDunn, Huda Al-Bahadili et al. · 2025 · Journal for ImmunoTherapy of Cancer
  81. Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma
    Nikola Bešič, Barbara Gazić · 2020 · Radiology and Oncology
  82. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves’ disease
    Nami Suzuki, Ai Yoshihara, Jaeduk Yoshimura Noh, Kazuya Kinoshita, Junki Ohnishi, Maki Saito, Kiminori Sugino, Kochi Ito · 2020 · Endocrine Journal
  83. Psoriasis Susceptibility 1 Candidate 1 (PSORS1C1) Polymorphism is Associated with Autoimmune Thyroid Disease in a Chinese Han Population
    Yanfei Jiang, Xudong Mao, Ronghua Song · 2021 · Immunological Investigations
  84. Thyroid Disorders in Children and Adolescents
    Scott A. Rivkees, Andrew J. Bauer · 2021 · Elsevier eBooks
  85. Prevalence and risk factors of untreated thyroid dysfunctions in the older Caucasian adults: Results of PolSenior 2 survey
    Piotr Kocełak, Małgorzata Mossakowska, Monika Puzianowska‐Kuźnicka, Krzysztof Sworczak, Adam Wyszomirski, Gabriela Handzlik‐Orlik, Adrian Stefański, Tomasz Roman Zdrojewski, Jerzy Tadeusz Chudek · 2022 · PLoS ONE
  86. A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease
    Daniela Gallo, Annarosaria De Vito, Rossella Roncoroni · 2022 · Endocrine
  87. Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse
    Tsz Wai Catherine Wong, Man Yee Shirley Wong · 2022 · Annals of Pediatric Endocrinology & Metabolism
  88. Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism
    Tang Xiaoyin, Bingwei Lu, Ding Min, Lin Yan, Li Ping, Bo Zhai · 2023 · CardioVascular and Interventional Radiology
  89. The value of FT4/TSH ratio in the differential diagnosis of Graves’ disease and subacute thyroiditis
    Yingjie Zhang, Yu Wang, Miao Liu, Lingge Wei, Jianmin Huang, Ziqian Dong, Meichao Guan, Weijie Wu, Jianqing Gao, Xiaojie Huang et al. · 2023 · Frontiers in Endocrinology
  90. Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort study
    Fumika Kamitani, Yuichi Nishioka, Miyuki Koizumi, Hiroki Nakajima, Yukako Kurematsu, Sadanori Okada, Shinichiro Kubo, Tomoya Myojin, Tatsuya Noda, Tomoaki Imamura et al. · 2023 · Scientific Reports
  91. Artificial Intelligence-Enabled Electrocardiography Contributes to Hyperthyroidism Detection and Outcome Prediction
    Lin, Chin, Kuo, Feng-Chih, Chau, Tom, Shih, Jui-Hu, Lin, Chin-Sheng, Chen, Chien-Chou, Lee, Chia-Cheng, Lin, Shih-Hua · 2024 · Communications Medicine
  92. Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients—a systematic review and meta-analysis
    Anqi Yuan, Jialu Wu, Hui Huang · 2024 · Frontiers in Endocrinology
  93. Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders
    Yee Weng Wong, Haris M. Haqqani, Peter Molenaar · 2024 · Handbook of experimental pharmacology
  94. US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease
    Mark Armin Lupo, Paul D. Olivo, Maximilian Luffy · 2024 · The Journal of Clinical Endocrinology & Metabolism
  95. Weight gain after treatment of Graves’ disease in children
    Guy Todd Alonso, Shona Rabon, Perrin C. White · 2017 · Clinical Endocrinology
  96. Color Duplex Doppler US can Follow up the Response of Radioiodine in Graves’ Disease by Evaluating the Thyroid Volume and Peak Systolic Velocity
    Thiago Adler Ralho Rodrigues dos Santos, Suemi Marui, Tomoco Watanabe · 2019 · Ultraschall in der Medizin - European Journal of Ultrasound
  97. Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease
    Yiting Yang, Jung‐Fu Chen, Shih‐Chen Tung, Ming‐Chun Kuo, Shao‐Wen Weng, Chen‐Kai Chou, Feng‐Chih Shen, Chih‐Min Chang, Chia-Jen Tsai, Cheng‐Feng Taso et al. · 2020 · Journal of the Formosan Medical Association
  98. American thyroid association guidelines are inconsistent with Grading of Recommendations Assessment, Development, and Evaluations—A meta-epidemiologic study
    Karen Gabriela Bautista-Orduno, Edgar Gerardo Dorsey-Treviño, José Gerardo González‐González, Dalia A. Castillo-Gonzalez, Mariana García-Leal, Karina Raygoza-Cortez, Michael R. Gionfriddo, René Rodríguez‐Gutiérrez · 2020 · Journal of Clinical Epidemiology
  99. Clinical experience of treating Graves’ hyperthyroidism complicated with malignancy—The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia
    Ken Okamura, Sachiko Bandai, Megumi Fujikawa, Kaori Sato, Takanari Kitazono · 2020 · Endocrine Journal
  100. Influence of Short-Term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease
    Rie Nishio, Toyoyoshi Uchida, Luka Suzuki · 2020 · Thyroid